Santori & Peters Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $980K | Sell |
40,679
-199
| -0.5% | -$5.21K | 0.28% | 32 |
|
|
2026
Q1 | $1.15M | Buy |
40,878
+186
| +0.5% | +$4.95K | 0.36% | 25 |
|
|
2025
Q4 | $1.01M | Buy |
40,692
+9
| +0% | +$227 | 0.35% | 26 |
|
|
2025
Q3 | $1.04M | Sell |
40,683
-25
| -0.1% | -$617 | 0.37% | 26 |
|
|
2025
Q2 | $987K | Buy |
40,708
+11,000
| +37% | +$257K | 0.36% | 27 |
|
|
2025
Q1 | $753K | Sell |
29,708
-569
| -2% | -$14.9K | 0.3% | 31 |
|
|
2024
Q4 | $803K | Sell |
30,277
-285
| -0.9% | -$7.73K | 0.31% | 32 |
|
|
2024
Q3 | $884K | Sell |
30,562
-305
| -1% | -$8.9K | 0.35% | 30 |
|
|
2024
Q2 | $864K | Sell |
30,867
-417
| -1% | -$11.5K | 0.37% | 27 |
|
|
2024
Q1 | $868K | Buy |
31,284
+30
| +0.1% | +$832 | 0.38% | 25 |
|
|
2023
Q4 | $900K | Hold |
31,254
| – | – | 0.43% | 24 |
|
|
2023
Q3 | $1.04M | Hold |
31,254
| – | – | 0.56% | 23 |
|
|
2023
Q2 | $1.15M | Hold |
31,254
| – | – | 0.57% | 24 |
|
|
2023
Q1 | $1.28M | Hold |
31,254
| – | – | 0.69% | 19 |
|
|
2022
Q4 | $1.6M | Hold |
31,254
| – | – | 0.94% | 15 |
|
|
2022
Q3 | $1.37M | Hold |
31,254
| – | – | 0.92% | 16 |
|
|
2022
Q2 | $1.64M | Sell |
31,254
-33
| -0.1% | -$1.68K | 1.06% | 14 |
|
|
2022
Q1 | $1.62M | Buy |
31,287
+915
| +3% | +$47.5K | 0.91% | 14 |
|
|
2021
Q4 | $1.79M | Hold |
30,372
| – | – | 0.95% | 14 |
|
|
2021
Q3 | $1.31M | Hold |
30,372
| – | – | 0.74% | 16 |
|
|
2021
Q2 | $1.19M | Buy |
30,372
+1
| +0% | +$39 | 0.67% | 17 |
|
|
2021
Q1 | $1.1M | Sell |
30,371
-360
| -1% | -$12.8K | 0.66% | 17 |
|
|
2020
Q4 | $1.14M | Sell |
30,731
-1,656
| -5% | -$60.7K | 0.64% | 16 |
|
|
2020
Q3 | $1.13M | Buy |
32,387
+531
| +2% | +$18.6K | 0.75% | 16 |
|
|
2020
Q2 | $988K | Buy |
31,856
+4
| +0% | +$136 | 0.76% | 16 |
|
|
2020
Q1 | $986K | Buy |
31,852
+5
| +0% | +$170 | 0.85% | 14 |
|
|
2019
Q4 | $1.18M | Buy |
31,847
+4
| +0% | +$142 | 0.78% | 17 |
|
|
2019
Q3 | $1.08M | Buy |
31,843
+4
| +0% | +$145 | 0.79% | 15 |
|
|
2019
Q2 | $1.31M | Buy |
31,839
+3
| +0% | +$119 | 0.95% | 15 |
|
|
2019
Q1 | $1.28M | Buy |
31,836
+3
| +0% | +$120 | 1.07% | 14 |
|
|
2018
Q4 | $1.32M | Buy |
31,833
+2
| +0% | +$83 | 1.17% | 13 |
|
|
2018
Q3 | $1.33M | Hold |
31,831
| – | – | 1.03% | 14 |
|
|
2018
Q2 | $1.09M | Hold |
31,831
| – | – | 0.96% | 14 |
|
|
2018
Q1 | $1.07M | Hold |
31,831
| – | – | 0.98% | 15 |
|
|
2017
Q4 | $1.03M | Buy |
+31,831
| New | +$1.09M | 0.93% | 14 |
|
Other funds holding PFE
Santori & Peters Inc's PFE Position: Q2 2026 in Review
Santori & Peters Inc reduced its Pfizer (PFE) stake by 0.49% in Q2 2026, selling an estimated $5.21K and leaving 40,679 shares worth $980K. The position accounts for 0.28% of the portfolio, ranked #32.
Santori & Peters Inc first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.79M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Santori & Peters Inc held 40,679 shares of Pfizer worth $980K as of Q2 2026.
- Santori & Peters Inc sold 199 Pfizer shares in Q2 2026, an estimated $5.21K.
- Pfizer made up 0.28% of Santori & Peters Inc's portfolio in Q2 2026, its #32 holding.
- Santori & Peters Inc first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Santori & Peters Inc's Pfizer position peaked at $1.79M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Santori & Peters Inc's 13F filing for Q2 2026, filed 24 Jul 2026.